尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Norrett Kevin. Insider active across 2 companies, notably Codexis, INC.. Cumulatively, 7 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €14k. History available since 21 February 2023. The latest transaction was disclosed on 21 January 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Norrett Kevin is Chief Operating Officer at Codexis, INC. (XNAS) and Chief Business Officer at Soleno Therapeutics INC (XNAS). He has 7 filings in total, and in the recent filings tracked, the period runs from 2023-02-21 to 2026-01-23, with EUR 14399 of buys and EUR 0 of sells, mainly linked to an attribution.